FDA recall D-1164-2016

Cantrell Drug Company · Class II · drug

Product

MIDAZOLAM HCl in 0.9% Sodium Chloride Injection, 2 mg/2 mL (1 mg/mL), in 2 mL syringe, Rx only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-001-16 UPC: 0100352533001161

Reason for recall

Subpotent Drug

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2015-08-21
Report date
2016-07-13
Termination date
2017-02-03
Voluntary/Mandated
Voluntary: Firm initiated
Location
Little Rock, AR, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1164-2016